Patent ID: 6358539
Filing Date: 2002-03-19
Classification: A61K,A61P,A61Q,Y10S

Abstract:
A pharmaceutical composition for reducing or eliminating the appearance of cellulite in a patient comprising:a sugar compound that is converted to a glycosaminoglycan in the patient in an amount sufficient to thicken the skin; a primary antioxidant component in an amount sufficient to substantially inhibit the activity of collagenase and elastase; at least one amino acid component in an amount sufficient to assist in the thickening of the skin; at least one transition metal component in an amount effective to bind collagen and elastic fibers and thicken the skin; at least one of either a fat burner to reduce absorption of fat in the digestive tract or prevent the production of fat, or a vascular dilator to improve blood supply to the skin; and chromium picolinate in an amount sufficient to facilitate entry of sugar into the cells to improve metabolism of fats by the body.